{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:37:33Z","timestamp":1758040653601,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Elsevier Evidence-Based Medicine Center"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.amjmed.2017.12.028","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:21:54Z","timestamp":1520295714000},"page":"623-629.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Off-Label Megestrol in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments"],"prefix":"10.1016","volume":"131","author":[{"given":"Jose M.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-2008","authenticated-orcid":false,"given":"Tatyana A.","family":"Shamliyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2017.12.028_bib0010","doi-asserted-by":"crossref","first-page":"212265","DOI":"10.7573\/dic.212265","article-title":"One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA","volume":"3","author":"Arthur","year":"2014","journal-title":"Drugs Context"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0020","first-page":"2341","article-title":"Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)","volume":"23","author":"LeBlanc","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0025","first-page":"191","article-title":"Systematic review of the multidimensional fatigue symptom inventory-short form","volume":"23","author":"Donovan","year":"2015","journal-title":"Support Care Cancer"},{"year":"2010","series-title":"Clinical practiceguidelines on cancer cachexia in advanced cancer patients","author":"Radbruch","key":"10.1016\/j.amjmed.2017.12.028_bib0030"},{"year":"2015","series-title":"Nutrition in Cancer Care\u2014for Health Professionals (PDQ)","author":"PDQ Supportive and Palliative Care Editorial Board ACI","key":"10.1016\/j.amjmed.2017.12.028_bib0035"},{"issue":"3","key":"10.1016\/j.amjmed.2017.12.028_bib0040","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000421-199210000-00008","article-title":"Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study","volume":"15","author":"Feliu","year":"1992","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/82.13.1127","article-title":"Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia","volume":"82","author":"Loprinzi","year":"1990","journal-title":"J Natl Cancer Inst"},{"issue":"1 suppl 2","key":"10.1016\/j.amjmed.2017.12.028_bib0055","first-page":"32","article-title":"Megestrol acetate in cancer cachexia","volume":"18","author":"Schmoll","year":"1991","journal-title":"Semin Oncol"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2017.12.028_bib0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000227127","article-title":"Risks and benefits of various therapies for cancer anorexia","volume":"49","author":"Schmoll","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0959-8049(96)00309-7","article-title":"Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy","volume":"33","author":"Fietkau","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0261-5614(94)90065-5","article-title":"Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients","volume":"13","author":"McMillan","year":"1994","journal-title":"Clin Nutr"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0075","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.2820690532","article-title":"Megestrol acetate in cancer anorexia and weight loss","volume":"69","author":"Tchekmedyian","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000421-199808000-00006","article-title":"Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia","volume":"21","author":"Vadell","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.1996.14.1.135","article-title":"Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate\/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study","volume":"14","author":"Rowland","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0090","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0959-8049(98)00219-6","article-title":"Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial","volume":"34","author":"De Conno","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","article-title":"Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib +\/\u2212 megestrol acetate for patients with cancer-related anorexia\/cachexia syndrome","volume":"31","author":"Madeddu","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0105","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/bjc.1996.297","article-title":"Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer","volume":"73","author":"Gebbia","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0110","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","article-title":"An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort","volume":"22","author":"Jatoi","year":"2004","journal-title":"J Clin Oncol"},{"author":"Par Pharmaceutical, Inc","key":"10.1016\/j.amjmed.2017.12.028_bib0115"},{"author":"Casado Herr\u00e1ez","key":"10.1016\/j.amjmed.2017.12.028_bib0120"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0125","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/030089161309900218","article-title":"Comparison of three different treatment modalities in the management of cancer cachexia","volume":"99","author":"Kanat","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0135","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/pbc.24828","article-title":"A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and\/or cancer therapy","volume":"61","author":"Cuvelier","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2017.12.028_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000227125","article-title":"Treatment of cancer weight loss in patients with advanced lung cancer","volume":"49","author":"Heckmayr","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/030089160208800406","article-title":"Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses","volume":"88","author":"Ulutin","year":"2002","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.amjmed.2017.12.028_bib0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF03344086","article-title":"High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate","volume":"29","author":"Chidakel","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.amjmed.2017.12.028_bib0155","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/cncr.22924","article-title":"Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer","volume":"110","author":"Dev","year":"2007","journal-title":"Cancer"},{"author":"Par Pharmaceutical, Inc.","key":"10.1016\/j.amjmed.2017.12.028_bib0160"},{"author":"Mayo Clinic","key":"10.1016\/j.amjmed.2017.12.028_bib0165"},{"author":"Alliance for Clinical Trials in Oncology","key":"10.1016\/j.amjmed.2017.12.028_bib0170"},{"author":"Wake Forest University Health Sciences","key":"10.1016\/j.amjmed.2017.12.028_bib0175"},{"author":"Wake Forest University Health Sciences","key":"10.1016\/j.amjmed.2017.12.028_bib0180"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318300184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318300184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:13:36Z","timestamp":1757582016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934318300184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0002934318300184"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.12.028","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-Label Megestrol in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}